THA Clinical Trials

2 recruiting

About THA Clinical Trials

Looking for clinical trials for THA? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new THA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about THA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 227 trials

Recruiting
Not Applicable

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

HIV-related StigmaUndiagnosed HIV InfectionPopulations That Are Reluctant to Test for HIV+3 more
University of Illinois at Chicago2,480 enrolled1 locationNCT06857071
Recruiting

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Sickle Cell DiseaseMalariaAlpha and Beta Thalassemia+1 more
National Institute of Allergy and Infectious Diseases (NIAID)300 enrolled1 locationNCT03937817
Recruiting
Phase 2

Role of Estrogen on Skeletal Outcomes in FHA

Bone DensityFHA (Functional Hypothalamic Amenorrhea)Bone Strength
University of Virginia150 enrolled2 locationsNCT07010146
Recruiting

Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)

AnophthalmiaMicrophthalmiaColoboma
National Eye Institute (NEI)600 enrolled1 locationNCT01778543
Recruiting
Phase 1Phase 2

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Refractory Acute Myeloid LeukemiaBlasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent Disease
Ohio State University Comprehensive Cancer Center28 enrolled2 locationsNCT04049539
Recruiting
Not Applicable

Head-Cancelled Virtual Reality for Ocular Cranial Nerve Palsies

Internuclear OphthalmoplegiaPalsy, Abducens
Kevin Houston40 enrolled2 locationsNCT06417216
Recruiting
Not Applicable

Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

Radiotherapy Side EffectEndocrine; DeficiencyHypothalamo-Pituitary Disorder
University Hospital, Angers230 enrolled3 locationsNCT06618703
Recruiting
Phase 4

Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery

Postoperative Pain ManagementOphthalmic Surgery
Zhongshan Ophthalmic Center, Sun Yat-sen University204 enrolled3 locationsNCT07269106
Recruiting
Not Applicable

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

Methamphetamine Use DisorderContingency Managment
Queen's Medical Center40 enrolled1 locationNCT06532370
Recruiting
Phase 3

MHB018A Treatment in Patients With Active Thyroid Eye Disease

Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd108 enrolled1 locationNCT06989918
Recruiting

An Observational Study of Individuals With Isolated Dystonia

Isolated/Primary Dystonia That Affects More Than One Region of the Body
Vima Therapeutics200 enrolled29 locationsNCT07111663
Recruiting
Phase 2

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

GerminomaBasal Ganglia GerminomaDiabetes Insipidus+3 more
Children's Oncology Group240 enrolled107 locationsNCT06368817
Recruiting
Not Applicable

Predicting Vital Pulp Treatment Outcomes in Symptomatic Pulpits Using Metabolic Biomarker

Reversible PulpitisPulp Disease, DentalPulpitis+1 more
Abeer Ghalib Abdul-khaliq60 enrolled1 locationNCT07452614
Recruiting
Phase 2

A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

Functional Hypothalamic Amenorrhea (FHA)
Regeneron Pharmaceuticals34 enrolled5 locationsNCT07235917
Recruiting
Phase 3

Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic Amenorrhea

FHA (Functional Hypothalamic Amenorrhea)
Massachusetts General Hospital114 enrolled2 locationsNCT06533865
Recruiting

A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines

Lateral Canthal Lines (LCL)Perioral Rhytids
Croma-Pharma GmbH70 enrolled1 locationNCT07492277
Recruiting
Phase 3

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Myasthaenia Gravis
Cartesian Therapeutics100 enrolled34 locationsNCT06799247
Recruiting
Phase 3

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled103 locationsNCT06609226
Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting
Phase 4

Duloxetine for Perioperative Pain in Hip Arthroplasty: A RCT

THA
University of Miami64 enrolled1 locationNCT06807866